TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,961,606 | +19.2% | 125,744 | -0.9% | 0.96% | +13.3% |
Q3 2022 | $1,646,000 | -9.6% | 126,946 | -2.0% | 0.85% | -8.7% |
Q2 2022 | $1,820,000 | -4.1% | 129,597 | -2.2% | 0.93% | +25.4% |
Q1 2022 | $1,898,000 | -0.9% | 132,516 | 0.0% | 0.74% | +2.6% |
Q4 2021 | $1,916,000 | -14.4% | 132,516 | -3.1% | 0.72% | -17.8% |
Q3 2021 | $2,239,000 | -3.4% | 136,693 | -0.8% | 0.88% | -2.1% |
Q2 2021 | $2,318,000 | +2.4% | 137,749 | +1.6% | 0.90% | +12.7% |
Q1 2021 | $2,264,000 | -5.8% | 135,550 | -0.6% | 0.80% | -15.9% |
Q4 2020 | $2,404,000 | +13.7% | 136,378 | -0.8% | 0.95% | -9.3% |
Q3 2020 | $2,115,000 | -4.0% | 137,430 | +11.9% | 1.04% | -17.5% |
Q2 2020 | $2,202,000 | +13.0% | 122,785 | -4.4% | 1.27% | -3.1% |
Q1 2020 | $1,949,000 | -25.9% | 128,421 | -3.7% | 1.31% | -3.9% |
Q4 2019 | $2,632,000 | +14.4% | 133,402 | -0.3% | 1.36% | +7.9% |
Q3 2019 | $2,301,000 | -2.8% | 133,804 | 0.0% | 1.26% | -0.9% |
Q2 2019 | $2,368,000 | -13.2% | 133,804 | -0.1% | 1.27% | -16.2% |
Q1 2019 | $2,729,000 | – | 133,980 | – | 1.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |